Joel S Owen

1PUBLICATIONS
0CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 04, 2023
Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin®) in Patients with Non-squamous Non-small Cell Lung Cancer.

Joel S Owen, Russell J Rackley, Matthew A Hummel

Pageof 1

Frequent Collaborators